Case report: MPN-eo with balanced rearrangement of MPRIP-PDGFRB t(5;17)(q32;p11), responding to low dose imatinib

Karolien Beel, Geneviève Ameye, Wim De Kelver, Lucienne Michaux

Abstract


We present a young patient with a rare eosinophilic myeloproliferative neoplasm MPN-eo with a balanced rearrangement of MPRIP-PDGFRB t(5;17)(q32;p11). This fusion gene was reported in only one other case in 2015. A personalized molecular test was developed with the diagnostic material of the patient. Our patient is in complete cytogenetic and molecular remission under low dose imatinib, two years after treatment initiation.


Full Text:

PDF


DOI: https://doi.org/10.5430/dcc.v8n3p1

Refbacks

  • There are currently no refbacks.


Discussion of Clinical Cases  ISSN 2375-8449(Print)  ISSN 2375-8473(Online)

Copyright © Sciedu Press 

To make sure that you can receive messages from us, please add the 'sciedu.ca' and ‘sciedupress.com’ domains to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', please check your 'spam' or 'junk' folder.